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ABSTRACT  The agonist effect of the dihydropyridine (DHP) (-)Bay K 8644 and 
the inhibitory effects of nine antagonist DHPs were studied  at a  constant mem- 
brane potential of 0 mV in Ca channels of skeletal muscle transverse tubules incor- 
porated  into  planar  lipid  bilayers.  Four  phenylalkylamines  (verapmlfil,  D600, 
D575, and D890) and d-c/s-diltiazem were also tested. In Ca channels activated by 
1 #M Bay K 8644,  the antagonists nifedipine, nitrendipine,  PN200-110,  nimodi- 
pine, and pure enantiomer antagonists (+)nimodipine,  (-)nimodipine, (+)Bay K 
8644, inhibited activity in the concentration range of 10 nM to 10/~M.  Effective 
doses (EDs0) were 2 to 10 times higher when DHPs were added to the internal side 
than when added to the external side. This sidedness arises from different struc- 
ture-activity relationships for DHPs on both sides of the Ca channel since the rank- 
ing potency of DHPs is PN200-110 >  (-)nimodipine >  nifedipine ~$207-180 on 
the external side while PN200-110  >  $207-180  >  nifedipine ~(-)nimodipine on 
the internal side. A comparison of EDs0's for inhibition of single channels by DHPs 
added to the external side and EDs0's for displacement of [3H]PN200-110 bound 
to the DHP receptor, revealed a good quantitative agreement. However, internal 
EDs0's of channels were consistently higher than radioligand binding affinities by 
up to two orders of magnitude. Evidently, Ca channels of skeletal muscle are func- 
tionally coupled to two DHP receptor sites on opposite sides of the membrane. 
INTRODUCTION 
Dihydropyridines (DHPs) are high affinity ligands of the Ca channel that specifically 
bind to a single polypeptide with a molecular weight of 175,000,  i.e., the al subunit 
of the DHP receptor (Galizzi et al., 1986; Striessnig et al., 1986; Sieber et al., 1987; 
Sharp et al.,  1987).  Two other groups of Ca antagonists,  phenylalkylamines (vera- 
pmnil derivatives) and benzothiazepines (diltiazem) are also bound specifically to the 
a~ subunit (Galizzi et al.,  1986; Sieber et al.,  1987). The primary sequence of the al 
subunit of the DHP receptor revealed a significant homology to that of the voltage- 
gated Na channel,  which led to the suggestion that the DHP receptor and the Ca 
channel are the same or closely associated proteins (Tanabe et al.,  1987; Ellis et al., 
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1988).  Three additional  polypeptides that  copurified with a~  as part  of the  DHP 
receptor  have  approximate  molecular  weights  as  (170,000),  /3  (52,000),  and  3' 
(31,000) (Takahashi et al., 1987; Catterall et al., 1988; Campbell et al., 1988; Hosey 
and Lazdunski,  1988; Leung et al.,  1988). Evidence that DHP receptors represent 
functional Ca channels has been provided by single-channel recordings of purified 
DHP receptor preparations in planar bilayers (Flockerzi et al.,  1986; Smith et al., 
1987) and 45Ca fluxes in liposomes (Curtis and Catterall,  1986; Home et al., 1988). 
However, the minimal polypeptide composition necessary to reconstitute functional 
Ca  channels varies widely among reports,  thus,  whether al  is  the  only structural 
component of the DHP-sensitive Ca channel is not known. 
The electrophysiological approach towards establishing the relation between Ca 
channels and DHP receptors has been to analyze quantitatively the pharmacological 
effects of DHPs.  In intestinal smooth muscle, there is essentially a  1:1  correlation 
between the competitive inhibition of [nH]nitrendipine binding and the inhibition 
of the  contractile response produced by a  large number of structurally different 
DHPs (Mannhold et al., 1982; Bolger et al., 1983; Sarmiento et al., 1984; Suet al., 
1985).  This suggested  a  tight  structural  coupling between Ca  channels  and  drug 
receptors in this tissue. Cardiac and skeletal muscle Ca channels are less sensitive to 
DHPs than expected from radioligand binding experiments (Lee and Tsien,  1983; 
Janis et al., 1984b, c, 1985; Palade and Almers, 1985; Schwartz et al., 1985; Williams 
et al.,  1985; Kokubun et al.,  1987; Lacerda and Brown, 1988). Recently, Hamilton 
et al., (1987) showed in cardiac Ca channels that numerical discrepancies between 
electrophysiological  and  radioligand  binding  affinities  are  larger  at  rest  than  at 
depolarized potentials. This has been interpreted to indicate that DHPs bind with 
higher affinities to Ca channels inactivated as a consequence of depolarization than 
to channels in their rest state. Similar conclusions were put forward earlier by others 
(Bean, 1984; Sanguinetti and Kass,  1984). 
In  skeletal muscle,  a  correlation between occupancy of the  DHP receptor and 
sensitivity of the  Ca  channel  to  the  same  DHPs  has  not been described and  we 
intend  to  do so in  the  present  report.  Recordings were  made  in  purified rabbit 
transverse tubules incorporated into planar lipid bilayers to take advantage of the 
fact that in this system the agonist DHP Bay K 8644 promotes a steady-state activity 
of Ca  channels  at  0  mV  (Affolter  and  Coronado,  1985,  1986;  Coronado  and 
Affolter,  1986a,  b;  Ehrlich  et  al.,  1986;  Rosenberg et  al.,  1986;  Coronado  and 
Smith, 1987; Ma and Coronado, 1988a, b; Vilven et al., 1988; Vilven and Coronado, 
1988; Valdivia and Coronado, 1988,  1989; Yatani et al.,  1988). This permitted the 
construction of dose-response curves for antagonist DHPs (in the presence of Bay K 
8644)  and a  comparison with radioligand binding affinities of DHPs. The former 
were measured from single-channel records and the latter from specific displace- 
ment  of  [3H]PN200-110  bound  to  the  DHP  receptor.  Both  sets  of data  were 
obtained under strictly identical conditions in the same preparation of purified rab- 
bit transverse tubules. To our knowledge, this type of comparison has not been pos- 
sible in the past.  Even though binding experiments in cells can be done under sta- 
tionary conditions with equilibration of the free and ligand-bound receptor (Green 
et al., 1985; Schwartz et al., 1985; Kokubun et al., 1987), Ca channel measurements 
cannot. Ca currents of cells are measured using pulse protocols during which chan- VALDIVIA  AND CORONADO  Internal and External Effects of Dihydropyridines  3 
nels open transiently and inactivate on a  time scale of milliseconds even in the pres- 
ence of agonist DHPs (Rosenberg et al., 1986;  Lacerda and Brown,  1988; Tsien et 
al.,  1988).  Our  results indicate a  strong quantitative correlation between the phar- 
macology of single Ca channels and that of DHP  receptors for a  set of ten DHPs, 
racemic and pure enantiomers. Furthermore, internal and external effects of DHPs 
studied separately suggested the presence of two drug receptor sites, a  low affinity 
site on the inside and a high affinity site on the outside. Single-channel affinities and 
binding affinities are essentially the same in the high affinity site. This strongly sug- 
gests  that  the  DHP-sensitive  Ca  channel  and  DHP  receptor  may share  common 
components or that they may represent different domains of the same structure. 
MATERIALS  AND  METHODS 
Preparation of Skeletal Muscle  Transverse  T,d~ules 
Transverse tubule vesicles were prepared from rabbit back and leg white muscle by a modifi- 
cation of the microsome fractionation procedure of Meissner (1984).  Light muscle micro- 
somes sedimenting at 10%/20% sucrose interface were used in all experiments. Portions of 
back and leg muscle are partially homogenized in buffer A (0.3 M sucrose, 20 mM HEPES- 
Tris, pH 7.2) with four 15-s pulses in a food processor. Tissue is completely homogenized in 3 
vol of buffer A  at high speed (2 x  30 s) in a  Waring blender (Waring Products Div., New 
Hartford, CT). The total homogenate is centrifuged for 30 rain at 2,600 g  (4,000 rpm) in a 
GSA-Sorvall rotor (Sorvall Instruments Div., Newton, CT). The supernatant is reserved and 
the pellet is rehomogenized in 3 vol of buffer A  and centrifuged as before. The combined 
2,600 g supernatants are centrifuged at 10,000 g  (8,000 rpm) in the GSA-Sorvall rotor and 
the  resulting supernatant  is discarded. The  10,000  g  pellets are resuspended and  briefly 
homogenized in 0.6  M  KCI, 5  mM Na-PIPES, pH 6.8, with two strokes of a  motor driven 
Teflon/glass homogenizer followed by incubation on ice for 1 h. Salt-treated microsomes are 
sedimented at 90,000 g  (32,000  rpm) in a  Beckman 35 rotor (Beckman Instruments,  Inc., 
Palo Alto, CA) and resuspended in 10% wt/wt sucrose, 0.4 M KCI, 5 mM Na-PIPES, pH 6.8. 
This material is layered onto discontinuous sucrose gradients (5 ml 20%, 8 mi 30%, 6 ml 35%, 
5 ml 40%) containing 0.4 M KCI, 5 mM Na-PIPES, pH 6.8, and centrifuged overnight (18 h) 
at 26,000 rpm in a Beckman SW.27 rotor. Fractions are collected from the sucrose interfaces 
by aspiration with a Pasteur pipette, diluted with ice-cold glass-distilled  water and pelleted at 
90,000 g  (32,000 rpm) in a Beckman 35 rotor. Pelleted membranes are suspended in 0.3 M 
sucrose, 0.1  M KCI, 5 mM NaoPIPES, pH 6.8, and frozen in liquid N~ until use. 
Planar Bilayer Assembly and Recording 
Lipid bilayers were cast from an equimolar mixture of phosphatidylethanolamine and phos- 
phatidylserine dissolved in decane at a concentration of 20 mg lipid/rnl. Lipid solution was 
spread across a 300 ~m diam polystyrene aperture separating two aqueous chambers desig- 
nated c/s and trans. The volume of each chamber was 3.0 and 3.5 ml, respectively. T  tubule 
vesicles (10-50/zg), were added to the c/s solution under stirring. C/s and tram solution were 
always the same; c/s: 100 mM BaCI~, 50 mM NaCI, 10 mM HEPES-Tris pH 7.0; trans: 50 mM 
NaCI,  10  mM HEPES-Tris, pH 7.0. All experiments were performed at room temperature. 
C/s solution was connected via an Ag/AgCI electrode and an agar/KC1 bridge to the head- 
stage input of a  List L/M EPC 7 amplifier (List Electronic DA-Eberstadt, FRG). Trans solu- 
tion was held at ground potential using the same electrode arrangement.  Records were fil- 
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MA), digitized at  1 point/ms on a  12obit A/D converter (Kiethley Instruments, Cleveland, 
OH) and fed into an IBM PC/AT computer (IBM  Instruments, Danbury, CT).  Drugs were 
added to either side from stock solutions dissolved in  100%  high quality methanol. Final 
methanol concentration in the chamber was always <1%. Control experiments showed that 
methanol, at concentrations used, had no effect on channel activity. 
Radioligand Binding Assays 
Samples of 15-40 #g protein/ml were incubated at room temperature in 1 ml of 50 mM 
NaCI, 10 mM Tris-HCl, pH 7.4, and the requierd concentration of (+)-[methyl-3H]PN200  - 
110  (0.05-7 nM). Specific binding was defined as the amount of radiolabel that could be 
displaced competitively by 1 #M cold PN200-110 or nitrendipine; [~H]PN200-110 was the 
last reagent added.  Incubation time varied from 40 to 60 min. For determination of total 
amount of [3H]PN200-110, a  small aliquot (20  #1) was removed before filtration. Binding 
was terminated by rapid filtration on Whatman GF/B or GF/F glass fiber filters.  Filters were 
washed twice with 5 ml of an ice-cold solution containing 20 mM Tris-HC1 pH 7.2 and 200 
mM choline chloride. Nonspecific binding to filters was negligible and independent of the 
presence of unlabeled ligand in the incubation medium. Radioactivity was measured in 6 ml 
of a Beckman HP/b scintillant on a Beckman LS 3801 scintillation counter. All experiments 
were performed under dim light to avoid photolysis of DHPs. Binding assays in the presence 
of divalent cations were performed essentially as described above. Free Ca in the range of 1 
to 1,000 gM was calculated using a standard computer program and was verified with a Ca 
electrode.  In experiments using high  divalent concentration, osmotic  pressure  was  kept 
approximately constant by replacing calcium chloride with choline chloride. Controls showed 
no effect  of choline chloride on  [sH]PN200-110  binding. Inhibition of  [3H]PN200-110 
binding by different DHPs was carried out using 0.2 nM [3H]PN200-110 and 20 #g/ml t 
tubule protein. Receptor occupancy by the radiolabel was 20-30%. Incubation solutions var- 
ied; solution A: 50 mM NaC1, 10 mM Tris-HC1, pH 7.2; solution B: 100 mM BaCI2, 10 mM 
Tris-HCl, pH 7.2; C and D: same as A and B, respectively, with 1 uM racemic Bay K 8644. 
Additional details are given in the legend of Fig. 14. Protein concentration  was determined by 
the Lowry method using bovine serum albumin as standard. 
Chemicals 
Phosphatidylethanolamine and phosphatidylserine were from Avanti Polar Lipids (Birming- 
ham,  AL).  n-Decane was  purchased  from  Aldrich  Chemical  Co.  (Milwaukee,  WI).  (+)- 
[methyl-3H]PN200-110  (71  Ci/mmol)  was  from  New  England  Nuclear  (Boston,  MA). 
Stereoisomerswith  >95%  purity,  (-)Bay  K  8644,  (+)Bay  K  8644,  (-)nimodipine, and 
(+)nimodipine, were made available to us by Dr. A. M. Brown (Baylor College of Medicine, 
Houston, TX).  The original source was  Dr.  Scriabine at  Miles  Institute, New Haven, CT. 
Antagonist SDZ 207-180 and PN200-100 were a gift of Dr. Ruegg at Sandoz Pharmaceuti- 
cal Div., Basel, Switzerland. Racemic Bay K 8644 was a gift from Dr. Scriabine at Miles Insti- 
tute, New Haven, CT. D600, D575, and D890 were made available to us by Dr. R. W. Tsien 
(Stanford  University, Palo  Alto,  CA).  The  original source  was  Knoll AG  (Ludwigshafen, 
FRG). 
RESULTS 
Inhibition of t  Tubule Ca Channels by Verapamil Derivatives and Diltiazem 
Ca channels from rat  t  tubules incorporated into planar bilayers are  activated by 
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tion and the internal end must face the c/s solution (Affolter and Coronado, 1985). 
This polarity of insertion was later confirmed pharmacologically by the use of the 
permanently charged phenylalkylamine, D890,  a  compound in which the  tertiary 
amine  of D600  is  made quaternary by replacement of H  with  CHs  (Affolter and 
Coronado, 1986). As shown in this initial study, Ca channels could be blocked when 
D890 was present in the c/s solution with no effects up to a trans drug concentration 
of 50 #M.  Hescheler et al.,  (1982) described the sidedness of D890 in ventricular 
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FIGURE  1.  Sidedness of blockade of Ca channels by D575.  Records labeled D575 trans and 
D575 c/~ are two separate experiments of Ba current at 0 mV in the presence of the quater- 
nary phenylalkylamine D575. The fraction of time in which one or more open channels were 
observed, fo, was 0.14 in trans control, 0.10 in tram 25 pM, and 0.105  in tram 50 #M.fo was 
0.13 in c/s control, 0.04 in c/s 25 t~M, and 0.02  in c/s 55 #M.  Duration of each record is 
los. 
heart  cells  in  which blocking of Ca currents was only seen  after injection of the 
compound into cells.  Evidently, the quaternary ammonium of D890 prevented the 
drug  from  freely  permeating  the  membrane  and  reaching  its  internally  located 
blocking site. 
Fig.  1 describes  a  similar  observation in  rabbit  t  tubules  using the  quaternary 
derivative D575. The latter differs from D890 in the number of methoxy groups, 6  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9 VOLUME  95  ￿9  1990 
five in D890  (same as D600) and four in D575.  Current carrier in all experiments 
was  100  mM BaCI2 present in the c/s solution;  50 mM NaCI was present in the cis 
and tra~  solutions.  The equilibrium  potential of ions are E~  <  -  100  mV (nomi- 
nally minus infinity), ENa =  0 mV, Eca=  + 35 mV. Current at 0  mV, the membrane 
potential of recordings of Fig.  1 and all others,  is in the outward direction  and is 
shown upwards. Control activity elicited by 1 #M racemic Bay K 8644 added to both 
sides is shown in top records. Approximately 90% of the fraction of time that chan- 
nels spent open in control was blocked by 55 #M D575 present in the c/s solution 
whereas the same trans concentration resulted in activity similar to that of control. 
Even  though  trans  D575  did  not  block  channels  in  an  all-or-none  manner,  it 
decreased conductance by -30%,  from 0.72 pA in control (SD =  0.13  pA) to 0.51 
pA (SD =  0.10 pA) at >5 #M.  This decrease in conductance was specific for D575 
and was not seen with D890 nor with the rest of phenylallkylamines tested. Forma- 
tion of low conductance states in the t tubule Ca channel have been observed after 
numerous in situ biochemical interventions that alter the bilayer lipid composition, 
including the addition of cholesterol to the trans aqueous phase (Ma and Coronado, 
1988a). Similar to the condensing effect of cholesterol in lipid bilayers (Simon et al., 
1982),  the trans effect of D575 could be mediated by disturbances in the phospho- 
lipid bilayer structure,  therefore it is unrelated  to occupancy of drug receptors in 
the Ca channel. 
Dose-response curves for the  two charged  phenylalkylamines,  D575  and  D890, 
and the tertiary amine, verapamil, are shown in Fig.  2.  From four separate experi- 
ments the EDs0's for internal D890 and D575 averaged 25 and 10 #M, respectively. 
The lack of trans blockade in either case confirmed the c/s-intracellular insertion of 
channels  in  the  rabbit preparation.  If the  rate  of passage of external  drug to an 
internal  receptor  was  the  only  factor  determining  the  side-dependent  effects  of 
D890  and D575,  these should not be present for tertiary phenylalkylamines given 
that the neutral form of the amine is lipid soluble (Uehara and Hume,  1985).  This 
conclusion  was  supported  by our  results  with  verapamil  but  not  those  with  the 
methoxy derivative of verapamil, D600. 
Experimentally, ED~0's for verapamil on either side of the channel were -2 #M. 
On  the  other hand,  the  effect of D600  which  has pI~ of 8.5,  which  is similar to 
verapamil (Uehara and Hume, 1985), is more peculiar and is shown in Fig. 3.  Trans 
blockade was monotonic, but cis D600 activated channels at low concentration (< 10 
#M) and inhibited activity at a much higher concentration (>30 #M). This asymme- 
try in the action of D600 is not explained by hydrophobic partitioning and suggests 
that the loci of action of D600 on the c/~ and trans sides may be entirely different. 
There  is  evidence  to  suggest  that  activation  or  inhibition  by  phenylalkylamines 
depends on regulatory components other than the DHP receptor.  In neuronal Ca 
channels,  D600  and other Ca antagonists behave as agonists after activation of G 
proteins presumably coupled to the Ca channel  (Scott and Dolphin,  1987).  In pla- 
nar bilayers, Gs has been shown to open t tubule Ca channels directly when added to 
the c/s chamber (Yatani et al.,  1988).  Thus it is plausible  that cis  D600  mimics in 
some way the action of an endogenous t tubule G  protein (Scherer et al.,  1987). 
Our observation differs from that made in neurons,  however, in several aspects. 
In neurons,  (a) activation of currents by D600 decays within minutes but is perma- VALDIVIA  AND CORONADO  Internal and External  Effects of Dihydropyridines  7 
nent  in our case  for up to 30 min,  (b)  D600 is applied  externally  but only internal 
drug potentiates  in our case,  (c)  the  DHP  nifedipine  also  potentiates  currents  but 
not in our case  (see  Fig.  13),  and  (d) potentiation  was observed after activation of 
currents with internally  applied  GTP-3,-S;  in our case,  the only agonist present was 
the DHP Bay K  8644. 
Another  extreme  case  of  asymmetric  blockade  by  a  tertiary  amine  was  found 
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using  the  benzothiazepine  d-c/s-diltiazem  and  is  shown  in  Fig.  4.  Over  the  range 
tested (1-100 #M) diltiazem was purely inhibitory with an internal EDs0 of 2 #M and 
an external  EDs0 of 32/~M  or 10-fold higher.  We consider this result  to be signifi- 
cant because  ~30%  of diltiazem is neutral,  thus lipid-soluble  at pH  7.2  (pI~ =  7.7). 
The opposite  actions of D600 along with the sidedness  of diltiazem reinforced  our 
view that different  drug receptors for the same compound may be present on the t 
tubule Ca channel. '~ 250, 
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FIGURE 3.  Activation and inhibition of Ca channels by D600. Channel recordings and dose- 
response curve for D600, a methoxy derivative of verapamil, fo was 0.14 and 0.30 in control 
and after c/s 10/~M D600, respectively. In trans addition, fo was 0.16 in control and 0.04 after 
1.5/~M D600. Bars correspond to two SDs of three separate recordings. 
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Activation and Inhibition by (-)Bay K  8644 
To test whether internal and external drug sites existed in the t tubule Ca channel it 
was  essential  to use  pure  stereoisomers  since  most Ca drugs  are  optically active, 
drug receptors in the Ca channel are highly stereospecific, and in some cases, the 
two stereoisomers of a  given compound have opposite electrophysiological effects 
(Garcia et al.,  1984;  Franckowiak et al.,  1985;  Williams et al.,  1985;  Ehrlich et al., 
1986; Striessnig et al.,  1986;  Hamilton et al.,  1987; Kokubun et al.,  1987). We sim- 
plified  the  problem  by  studying  in  detail  a  single  compound,  the  agonist  DHP 
(-)Bay  K  8644  (Franckowiak  et  al.,  1985;  Lacerda  and  Brown,  1988).  This  is  a 
chemically pure stereoisomer for which dose-response curves on either side of the 
channel could be measured in the absence of other compounds. 
When  racemic Bay  K  8644  is  used  in  planar bilayer recordings  of skeletal  Ca 
channel,  micromolar levels are usually required  to induce  openings  (Affolter and 
Coronado,  1985). With the pure agonist enantiomer (-)Bay K 8644, we found that 
openings could be elicited with nanomolar concentrations. Fig. 5 shows representa- 
tive  traces  at  0  mV  of Ca  channels  activated  with  increasing  concentrations  of 
(-)Bay K  8644  added to the external (tram) solution.  All traces are from a  single 
experiment  (out  of three)  in  which  t  tubules  were  added  to  the  c/s  solution  and 
agonist to the tram solution without breakdown of the film throughout  the entire 
recording.  This ensured  that the agonist was in contact with  the tram face of the 
inserted  channel  only.  Unlike in  rat  (Affolter and Coronado,  1985),  in  the rabbit 
preparation we found no measurable activity in the absence of agonist. Threshold 
for activation was ~10 nM (-)Bay K 8644. At this concentration we did not observe 
the  long open events characteristic  of channels  activated by racemic Bay K  8644 
described  in heart  (Hess et  al.,  1984),  and by us in  skeletal muscle  (Affolter and 
Coronado,  1985).  At 25  nM and above, frequency of openings,  channel  lifetime, 
and  fraction of time spent open increased  with  concentration,  more in  line with 
results using the racemic compound. 
As  shown  in  Fig.  6,  in  the  range of 10  to  250  nM  (-)Bay  K  8644  there is an 
approximately linear increase in the fraction of time in which one or more channels 
were open. On the other hand, the frequency of openings or number of events per 
unit time, had a  plateau at concentrations  above 100 nM and decreased consider- 
ably at 250 nM (-)Bay K 8644. By comparing the left and right panels of Fig. 6 it is 
clear that above 100 nM (-)Bay K 8644 the fraction of time in which one or more 
channels were open increases at the expense of longer openings since the frequency 
of events decreases considerably at high drug concentration.  Over the range tested 
we observed no changes in channel  conductance  of the kind reported by Lacerda 
and Brown  (1988)  in heart  cells or of the kind seen in c/s additions  of (-)Bay K 
8644  (see Fig. 8 below). 
The distribution of observable lifetimes at a cutoff frequency of 100 Hz was biex- 
ponential with both time constants increasing with drug concentration. Time histo- 
grams are shown as insets in Fig. 7. Histograms were plotted in a cumulative form as 
percent of events lasting the specified time or longer. Each fitted exponential is also 
shown in the histograms. A  time constant that fitted the brief events, denominated 
fast r, is predominant at 10 and 25 nM, while a second component, slow r, is more 
apparent at higher doses. The upper and lower panels of Fig. 7 show that fast r  and 10  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY ￿9 VOLUME  95  ￿9  1990 
slow r  reached a plateau at ~300 nM with limiting values of 70 and 400 ms, respec- 
tively. The midpoint (EDs0)  for the concentration dependence of the fast z and slow 
~- was 80 and 68 nM, respectively. This affinity is in the same range as the  ED~0 of 
(-)Bay  K  8644  necessary  to  displace  bound  [3H]PN200-110  in  ligand  binding 
experiments  (see the legend to Fig.  14). Although lifetimes of open channels had a 
tendency to saturate with increasing concentration of (-)Bay K  8644,  this was not 
(-)BAY  K  B644,  trans 
10  nN 
25 nN 
50 n.  I1.25 p^ 
lO0 nN 
150 nN 
200  n#4 
FIGURE 5.  Activation  of  Ca  chan- 
nels by trans (-)Bay K 8644. Activity 
at  0  mV  is  shown  as  a  function  of 
(-)Bay  K  8644  added  to  the  trans 
side  (racemic  Bay  K  8644  was  not 
present).  No openings were seen  in 
the absence of the agonist. The two 
records  at  each  concentration  are 
representative  of 150 s of recording 
time  at  that  concentration.  All  data 
are from the same recording. 
the  case  for  the  dose-response  curve  of open  probability.  On  the  contrary,  the 
experimental  NP  product  (N is the  number of channels,  P  is  the  open probability 
per channel)  increased  with  concentration  over the  same range  in which lifetimes 
were  actually constant  (compare  the  left  panel  of Fig.  6  with  Fig.  7).  In separate 
experiments covering the micromolar range of tram  (-)Bay K 8644, from 0.5 to 10 
#M, the lifetime of channels and the NP  product was invariant with concentration. VALDIVIA AND CORONADO 
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channels were observed relative to  144  s of total recorded time. Open events are the total 
number of openings during 72 s.  Single points are from one recording; bars are two SDs of 
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FIGURE 7.  Slow and  fast life- 
times of Ca channels  activated 
by tram (-)Bay K 8644.  Open 
time  histograms  and  fitted 
exponentials  are  shown  as 
insets at the indicated concen- 
trations  of  (-)Bay  K  8644. 
Numbers of openings were 48, 
133,  162,  and  191  for 25,  50, 
100,  and 200  nM, respectively 
(events  <2 ms were excluded). 
Main curve in top and bottom 
represent  a  fit of the concen- 
tration  dependence  of  fast  r 
and  slow r  to a  single binding 
site  isotherm  with  Kd'S  of  80 
and 68 nM, respectively. 12  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  95  ￿9  1990 
Both parameters saturate with increasing concentration of (-)Bay K 8644 although 
the  NP  product  does  so  at  concentrations  much  higher  than  those  measured  in 
radioligand binding experiments. 
When (-)Bay K  8644 was added to the internal side, rather than to the external 
solution,  the  results  were  surprising.  Based  on  the  high  lipid solubility of DHPs 
(Rhodes et al., 1985) we expect c/s effects to be qualitatively similar to those seen on 
the trans side. Instead, cis (-)Bay K 8644 did not activate channels until the concen- 
tration reached the micromolar range  (0.5 #M).  At low nanomolar concentrations 
(-)BAY  K  8644,  cis 
0.5/.zM 
1.0/zM 
&q:,LJ~2  "  ,:;  .....  .....  v ....  rtr  ",a 
2.0/.zM 
4. O/.zM 
7.0 /..*M 
...~1.25  p^ 
l.  Os 
FIGURE 8.  C/s  activation  of  Ca 
channels by (-)Bay K 8644. Channel 
currents in Ba at 0 mV and the indi- 
cated  concentrations  of  (-)Bay  K 
8644  added to the c/s side (racemic 
Bay K 8644 was not present).fo at 0.5 
#M  cis  (-)Bay  K  8644,  the  lowest 
concentration  at  which  channels 
were observed, was 0.28. fo decreased 
to 0.10  at c/s 7  gM  (-)Bay K  8644. 
Mean channel conductance was 1.05, 
0.85, 0.87, 0.75, and 0.88 pA at 0.5, 
1.0,  2.0,  4.0,  and  7.0  #M,  respec- 
tively (largest SD was 0.15 pA). Rec- 
ords are from a single experiment. 
we  failed to  record openings with  a  stable frequency  even  though  a  few  sporadic 
events were observed in some experiments. Furthermore, Fig. 8  shows that concen- 
trations above this threshold decreased mean duration, which is the opposite of the 
result seen with tram  (-)Bay  K  8644.  At cis 0.5 #M  (-)Bay K  8644  there is also a 
significant increase  in  mean  amplitude  of channels  from  0.72  pA  (SD =  0.1  pA, 
n  =  1,590)  for trans  activation, to  0.99  pA (SD =  0.15,  n  =  210)  for the c/s activa- 
tion. This difference translates in an increase in slope conductance from -12  to 17 
pS at 0  mV. Amplitude differences induced by c/s or trans agonist were less notice- VALDIVIA  AND CORONADO  Internal and External Effects of Dihydropyridines  13 
able at c/s concentrations above 5  pM (-)Bay K  8644.  Time histograms of collected 
openings  from  two  separate  recordings  at  four  c/s  concentrations  are  shown  as 
insets it~ Fig. 9. Fast and slow time constants decrease from 35 and 400 ms at 0.5 pM 
to  22  and 80  ms at 250  riM, respectively. Evidently, (-)Bay  K  8644  added to the 
internal and external solution appears to activate channels  by reaching into func- 
tionally different DHP receptor sites. 
Sidedness of Inhibition of PN200-110 and Other DHPs 
The significant difference between c/s and trans activation by agonist (-)Bay K 8644 
prompted  the  question  of whether  the  same  sidedness was  present  for antagonist 
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FIGURE 9.  Slow and fast life- 
times of Ca channels activated 
by  c/s  (-)Bay  K  8644.  Data 
from  two  separate recordings 
were  pooled  and  used  to  fit 
time constants. Histograms are 
,  shown as insets at the indicated 
concentrations  of  (-)Bay  K 
8644.  Number  of  openings 
were  210,  189,  178,  and  194 
for 0.5,  1.0,  2.0,  and 7.0 pM, 
respectively  (events  <2  ms 
1.0  were excluded). 
10.0 
DHPs.  Fig.  10  shows  trans  inhibition  by the  high  affinity antagonist  PN200-110 
while a  comparison of c/s and trans effects is shown in Fig.  11.  In these and subse- 
quent experiments, channels were activated by 1 pM racemic Bay K 8644 present in 
both sides. This concentration was sufficient to activate channels internally (Fig.  7) 
and externally (Fig. 8). Control activity therefore represented a state in which both 
"internal"  and  "external"  drug  receptors were  occupied by agonist.  Activity was 
measured as the fraction of time that one or more channels spent open averaged 
over 144 s of recording time. As shown in records of Fig.  10, a  tram concentration 
of  10  nM  PN200-110  was  sufficient  to  induce  blocked times  that  lasted  5-10  s, 
which  were  not  seen  in  control.  Almost  complete  inhibition  of opening  events 14  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9 VOLUME  95 . 1990 
occurred  at  100  nM  or  higher  concentrations.  Qualitatively,  the  same  kinetic 
sequence seen in activation by tram (-)Bay K 8644 is reverted by trans PN200-110. 
That is, long openings are blocked at low antagonist concentration while short open- 
ings  are  blocked at  high  concentration.  Fig.  11  shows  that  cis-added  PN200-110 
(150  nM)  had  virtually no  effect  while  the  lower  tram  concentration  (100  nM) 
blocked most openings. 
PN200-IlO,  irons 
CONTROL 
5~ 
10 nH 
".  j.:;  ~:  .:~';  ;.  :"  "~'."  ~  ~-.:.."~,:.'c:.~-'~ 
20 
FIGURE 10.  Trans  inhibition of Ca 
channels by PN200-110.  Ba currents 
were recorded at 0  mV in the pres- 
ence of  1 pM  racemic Bay K  8644. 
The  antagonist  PN200-110  was 
added  to  the  trans  side  only. fo  for 
control averaged 0.24 and decreased 
to 0.01  at 100 nM PN200-110. 
60  nN 
100  nM 
i 
1.25 pA 
Dose-response curves constructed separately for c/s and trans additions of DHPs 
are  shown  in Fig.  12  for PN200-110,  nitrendipine,  (-)nimodipine,  and  (+)Bay  K 
8644.  Each point in each dose-response curve represents  144  s of monitored activ- 
ity. For all DHPs  tested the apparent affinity of inhibition was higher when  drugs 
were  added  to  the  trans  solution  as  compared  with  the  c/s  solution.  In  the  most 
extreme  case,  that  of  PN200-110,  there  is  an  almost  parallel  shift  of the  dose- 
response curve by 1.2 orders of magnitude towards lower affinity when the DHP is VALDIVIA  AND CORONADO  Internal and External Effects of Dihydropyridines  15 
added internally (tram 10 nM vs. c/s 168 nM). In the case of nitrendipine,  (-)nimod- 
ipine, or (+)Bay K 8644,  the shift is less, ~0.3-0.4 orders of magnitude. Sidedness 
was observed with various degrees in all tested DHPs except in the case of the qua- 
ternary DHP $207-180  (c/s and trans  ED~0's  for all  DHPs  tested are  given in  the 
legend to Fig. 15). Except for nitrendipine, all trans EDs0's are in the submicromolar 
range with PN200-100  displaying the highest affinity. 
Neither c/s nor trans affinities for DHPs changed when Bay K 8644 was separately 
present on the c/s or trans sides of the channel. This is shown in Fig.  13 where the 
four dose-response curves are for nifedipine added either to the cis (circles)  or the 
tram  (squares)  sides with  racemic Bay K  8644  present in  the cis  (filled symbols)  or 
trans  (open symbols)  solution.  Each  curve corresponds  to a  separate experiment in 
which the planar bilayer never broke during the recording and there was no mixing 
CONTROL 
150 nM PN200-110, cis 
CONTROL 
1.25 pA 
100 nM PN200-110, trons  '1.O = 
.....  I  ....... 4.1 ......................  ~  ....... 
FIGURE 11.  C/s and tram PN200-110  blockade of Ca channels.  Single-channel recordings 
are for Ba current at 0 mV. C/s and tram additions are from separate recordings, fo was 0.14 
before and 0.12  after c/s addition of 150  nM PN200-110.  In tram addition fo was 0.16 in 
control and 0.0048 after 100 nM PN200-110. 
of c/s and tram solutions. Curves for c/s and tram inhibition are essentially indepen- 
dent  of the  presence of agonist  in  the  same or opposite  solution.  The  observed 
sidedness  of DHP  antagonist  is  therefore  independent  on  the  occupancy of the 
channel by Bay K 8644. 
Comparison of Ca Channel and DHP Receptor A Oinities for DHPs 
To  compare the  c/s  and tram  EDs0's of channels with ligand  binding  affinities of 
DHPs we first studied in Fig.  14 the effect of BaCI~ and Bay K 8644 on binding of 
[3H]PN200-110  and its inhibition by unlabeled PN200-110  (top right),  nimodipine 
(top/eft), nifedipine (bottom/eft),  and nitrendipine  (bottom  right).  Similar curves were 
made for all DHPs tested in single-channel experiments (see legend to Fig. 14). Bar- 
ium ions and Bay K  8644  were present at the same concentrations used in single- 16  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY-  VOLUME  95  ￿9  1990 
channel recordings.  We avoided the use of [SH]Bay K 8644 as radioligand for tech- 
nical reasons.  In cardiac (Janis et al.,  1984a) as well in skeletal muscle (Valdivia H., 
and  R.  Coronado,  unpublished  observations)  bound  [3H]Bay  K  8644  shows  a 
biphasic  dissociation  curve  when  displaced  by other  DHPs.  At  the  concentration 
used  for electrophysiological  experiments  (1  taM),  the  exact  relative  occupancy of 
high and low affinity sites by Bay K 8644 is difficult to measure and any interpreta- 
tion of the  relative  potency of antagonists  to displace  [3H]Bay K  8644  from either 
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FIGURE  ] 2.  Dose response of DHPs on c/s and trans sides of the Ca channel. Dose-response 
curves at 0 mV are shown for the antagonist DHPs PN200-110, nitrendipine,  (-)nimodipine, 
and (+)Bay K 8644.fo was measured during 150 s at each concentration. C/s and trans titra- 
tions were performed on different experiments, fo control was measured during 180-300 s 
before drug addition and was used to normalized data.  Bars represent  two standard devia- 
tions of data points with the largest errors. Each point is the average of three separate titra- 
tions. 
site  is complex.  Also, even at nanomolar concentration,  [3H]Bay K  8644 displays a 
higb nonspecific binding which accounts for the poor signal-to-noise ratio reported 
for  this  compound  (Janis  et  al.,  1984a;  Rampe  et  al.,  1989).  We  used  instead 
(+)[~H]PN200-110, which is a high affinity, low background DHP that (a) binds to a 
single class of sites  (Janis et al.,  1985),  (b) has been shown to track the Bay K 8644 
binding site in competition experiments (Rampe et al.,  1989), and (c) its radioligand VALDIVlA  AND CORONADO  Internal and External Effects of Dihydropyridines  17 
binding properties has been extensively characterized in skeletal muscle transverse 
tubules (Fosset et al., 1983; Borsotto et al., 1984). In 50 mM NaCI and contaminant 
levels of divalents, a  Scatchard analysis of [sH]PN200-110  binding to our prepara- 
tion of t  tubules revealed an average density of binding sites (Bma~) of 40 pmol/mg 
and Kd of 0.78  nM  (not shown)  which  is in excellent agreement with  the binding 
capacity of DHPs reported by Fosset et al. (1983) and the binding affinities of Bor- 
sotto et al. (1984) in the same preparation. 
The top left of Fig.  14  shows specific binding of [sH]PN200-110  and displace- 
ment by unlabeled PN200-110  in 50  nM  NaCI (open circles).  The  ED~0 of the dis- 
placement was 1 nM PN200-110  and the apparent Hill coefficient was 1.03.  Bind- 
ing parameters were obtained  from least-squares  regression  of data  from three  t 
tubule preparations. All curves in Fig.  14 were scaled using the specific binding of 
0.2 nM [3H]PN200-110 as control. At that drug and receptor concentration, recep- 
tor occupancy was no more than 25%.  Hence, EDs0's for inhibition of [3H]PN200- 
110 binding closely follow the apparent affinity of the inhibitor DHP for the DHP 
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FIGURE 13.  Inhibition  of Ca 
channels  by nifedipine  in  the 
presence of c/s or tram Bay K 
8644. Dose-response curves at 
0  mV were  obtained  in  four 
separate experiments for each 
of  the  following  conditions. 
Filled symbols: Ca channels acti- 
vated  by  1  #M  Bay  K  8644 
added  to  the c/s side  with  ni- 
fedipine  added  to  the cis  (cir- 
receptor  (see  Cheng  and  Prusoff,  1973).  When  the  displacement  by  unlabeled 
PN200-110  is done  in  the  presence of 1  #M  racemic Bay K  8644  (Fig.  14,  open 
squares),  the inhibition curve was displaced to the right with an apparent Kd of 10 
nM and an apparent Hill coefficient 1.05. Similar displacements were present for all 
DHPs tested (compare open circles and open squares in Fig.  14). The absolute spe- 
cific binding in  the  presence of 1  #M  Bay K  8644  was ~30%  of that seen in the 
absence of the agonist since Bay K 8644 itself displaces PN200-110 with an EDs0 of 
~ 100 nM (not shown). 
The effect of 0.1  M BaCI~ on binding parameters of PN200-110 are shown in Fig. 
14 (top left) in the absence (filled circles) or presence (filled squares)  of 1 I~M Bay K 
8644.  An  increasing  concentration  of  BaCI~  in  the  miUimolar  range  inhibited 
PN200-100  binding,  which is again in agreement with the results of Fosset et al., 
(1983)  and Galizzi et al.,  (1984)  in the same preparation.  In our study,  0.1  M  Ba 
decreased the Bn= of PN200-110 binding by ~60% without a major change in affin- 
ity (average Bm= of 40 pmol/mg, Kd of 0.78 nM in 50 mM NaCI; and average Br,= = 
m 
0.1  1.0  10.0  cles)  or  tram  (squares)  side. 
NIFEDIPINE [/~M]  Empty symbols: Ca channels acti- 
vated by 1 #M Bay K 8644 added to the tram side and nifedipine added to the cis (circles) or 
trans (squares) side.  Points are the fraction of time that one or more channels spent open 
averaged over 144 s and normalized relative to activity in the absence of nifedipine. 18  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY.  VOLUME  95 ￿9 1990 
16 pmol/mg, Kd =  0.92 nM, in 50 mM NaCI plus 0.1  M  BaCI~; data not shown). In 
addition  to  decreasing  the  number  of available sites,  Fig.  14  shows  that  barium 
induced an unexpected change in the apparent Hill coefficient of the displacement 
reaction, from close to unity in 50 mM Na (open circles)  to 0.4-0.6 in 50 mM Na plus 
100  mM Ba (filled circles).  The change in steepness of inhibition induced by barium 
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Displacement  of  PN200-110  binding  by  DHPs  under  various  conditions. 
[3H]PN200-110  (0.2 nM) was incubated with 10-30 #g rabbit t tubule vesicles and the indi- 
cated concentrations of racemic PN200-110,  (+)-nimodipine, nifedipine, and nitrendipine. 
Incubation solutions were, solution A: 50 mM NaCl, 10 mM HEPES-Tris pH 7.2 (empty cir- 
cles); solution B:  100  mM  BaCI~, 50  mM NaC1,  10  mM  HEPES-Tris pH  7.2 (filled circles); 
solution C: solution A plus 1 ~M Bay K 8644 (empty squares); solution D: solution B plus 1 #M 
Bay K 8644 (filled squares). Specific binding was defined as counts per minute retained in the 
absence of displacer minus counts per minute retained in the presence of 1 #M PN200-110. 
This number was normalized to 100% and, in absolute terms, was ~3,000 cpm for solution A 
and 2,000 cpm for solution B. In experiments using Bay K 8644 (solutions C and D) only a 
third of these values were retained. Signal-to-noise ratio when using solutions C and D was 
increased  by  doubling  the  amount  of  protein  and  volume  of  incubation  so  that  free 
[3H]PN200-110  was kept constant. EDs0's in units of-log[DHP] for displacement of bound 
[3H]PN200-110 in the absence and presence of 1 #M Bay K 8644 were, respectively, (-)Bay 
K  8644:  7.0,  6.3;  (+)Bay K  8644:  8.2,  6.6;  nimodipine: 8.0,  6.5;  (-)nimodipine: 8.4,  7.4; 
(+)nimodipine:  8.1,  6.5;  nitrendipine:  8.7,  7.4;  S-207-180:  7.4,  6.2;  nifedipine: 8.3,  7.0; 
PN200-110:  9.0, 8.0. All SDs were within 0.2 log units of reported mean. VALDIVIA  AND CORONADO Internal  and External Effects of Dihydropymtines  19 
can be clearly seen in each of the four displacement curves in Fig.  14 and, in fact, it 
was  present  for all  DHPs.  Even  more  peculiar  is  the  fact  that  no  change  in  Hill 
coefficient was observed when displacement was done in the presence of 1 #M Bay 
K  8644  (compare open and filled squares in Fig.  14).  We interpret  this change in 
steepness  as  a  manifestation  of two  interacting  DHP  sites  one  of which  is  either 
unmasked or induced by high barium. Direct electrophysiological evidence favoring 
two DHP sites was found by comparing c/s and tram EDs0's with radioligand binding 
EDs0's for all DHPs tested. 
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FIGURE 15.  Correlation between ligand binding aaffmities and DHP blockade of Ca chan- 
nels. (Left panel) Ligand binding EDs0's of DHPs obtained by displacement of [3H]PN200-110 
(y-axis) are compared with single-channel EDs0's obtained by inhibition of fraction open time 
using c/s-added DHPs (x-axis). In both sets, experiments were performed at 0 mV in the pres- 
ence of 1/~M racemic Bay K 8644, 0.1 M Ba. Dotted line has a slope equal to 1. (Right panel) 
Ligand binding EDs0's are compared with EDs0'S for activation [(-)Bay K 8644)] and inhibi- 
tion (all other DHPs) of fraction open time using tram-added DHPs (x-axis). As channel acti- 
vation by (-)Bay K 8644 did not require  the presence of racemic Bay K 8644, its  single- 
channel EDs0 was compared with ligand binding EDs0 in the absence of racemic agonist. The 
dotted line has a slope equal to 1. Channel EDs0'S in -Iog[DHP] units were for c/s and tram, 
respectively: PN200-110 (PN): 6.8, 8.0; nifedipine (NIF): 5.7, 6.5; $207-180 ($207): 6.3, 6.4; 
nitrendipine  (NIT): 4.7,  5.7; (+)nimodipine  [(+)NIM]: 5.0, 6.4; (-)nimodipine  [(-)NIM]: 
5.7,  6.8; nimodipine (NIM): 5.1, 6.2; (+)Bay K 8644  [(+)BAYk]: 4.9,  6.5; (-)Bay K 8644 
[(-)BAYk]:--7.2.  DHP receptor  ICs0's in both  graphs were  PN200:  8.0;  nifedipine:  7.0; 
$207-180: 6.2; nitrendipine:  7.4; (+)nimodipine: 6.5; (-)nimodipine:  7.4; nimodipine: 6.5; 
(+)Bay K 8644: 6.6; (-) Bay K 8644: 6.3. All SDs were within 0.2 log units of the reported 
mean. 
Correlation of EDs0'S in single-channel and binding experiments are shown in Fig. 
15.  C/s addition of DHPs (/eft panel)  and tram addition  of DHPs (right panel) were 
plotted separately while binding data is the same for both figures. The dotted line in 
both graphs has  a  slope  of unity.  All x, y  entries  are  the  same  given in the figure 
legend. The slope (n) and correlation coefficient (r) for the set of x, y pairs was n  = 
0.45,  r  =  0.85  in  the  left  panel  and n  =  0.8,  r  =  0.87  in  the  fight  panel.  When 
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cases,  the slope and correlation coefficient became n  =  0.55,  r  =  0.89  (left panel) 
and n  =  0.9, r  =  0.92 (right panel). 
As a  whole we conclude  that the correlation holds  quantitatively for trans addi- 
tions or DHPs but not for c/s additions. Surprisingly, the only DHP that shows equal 
effects on both sides and has a  1:1  correspondence in binding and channel experi- 
ments  is  the  permanently charged  DHP  $207-180.  In -log units  $207-108  shows 
EDs0's 6.3,  6.4,  and  6.2  for cis,  tram,  and binding affinities,  respectively.  In fact, 
$207-180 is the only DHP that in cis-addition experiments is close to the dotted line. 
All other DHPs in c/s-addition experiments are below the dotted line implying that 
channel affinities are lower than binding affinities. In the most severe cases, there is 
an  approximate  50-fold  lower channel  affinity for c/s-added  (+)Bay  K  8644  and 
(-)nimodipine and a  500-fold lower channel affinity for c/s-added nitrendipine.  In 
contrast, tram-added  DHPs and binding data shows a  remarkable agreement, with 
the sole exception of nitrendipine.  For tram nitrendipine the discrepancy is 50-fold, 
not 500-fold as for cis-added drug. 
DISCUSSION 
In the present report we outlined  the pharmacology of the Ca channel of skeletal 
muscle incorporated into planar bilayers and correlated EDs0's for single channels 
and  DHP receptors.  Given the  open chamber arrangement of planar bilayers we 
were naturally inclined to test drug effects separately on the cytosolic and extracel- 
lular sides. Significant differences in internal and external affinities were found for 
the three classes of Ca antagonists (namely DHPs, phenylalkylamines, and diltiazem) 
although  only the  DHPs were  studied  with  sufficient detail.  The pharmacokinetic 
interactions among these drugs,  inferred from radioligand binding experiments, is 
complex.  In skeletal muscle,  DHPs bind with nanomolar affinity to an apparently 
single class of sites in the a 1 peptide (reviewed by Campbell et al.,  1988; Catterall et 
al.,  1988; Hosey and Lazdunsky,  1988).  Binding of DHPs is enhanced by benzothi- 
azepines such as diltiazem and inhibited by phenylalkylamines such as verapamil via 
drug  occupancy of a  separate  set of receptors  allosterically coupled  to  the  DHP 
receptor. Photoreactive derivatives of the three classes of drugs compete for cova- 
lent binding to the a 1 peptide of the DHP receptor (Galizzi et al.,  1986; Stiessnig et 
al., 1986; Siber et al., 1987), which suggests that the same protein contains the three 
receptor  sites  for  calcium  antagonists.  Our  results  differ  from  this  view  in  that 
DHPs act on  t  tubule  Ca channels  as if they were bound  to more than  one  site. 
Inasmuch as constant channel activity at 0  mV was induced in all cases by agonist 
DHP Bay K 8644, we investigated in detail whether the sidedness of DHP blockers 
varied with the presence of c/s or trans agonist. The EDs0's for nifedipine shown in 
Fig.  l 3  indicated  that  this was not  the  case.  This result  rules  out  the  most trivial 
explanation of sidedness, which is that the agonists could have interfered with the 
partitioning  of the  antagonists  in  the  lipid phase when  both  were  present  in  the 
same solution.  Instead, sided-dependent effects appeared to be an intrinsic charac- 
teristic  of the  Ca  channel  protein  since  they were  present  even when  (-)Bay  K 
8644,  the  pure  stereoisomer  agonist  (Francowiak  et  al.,  1985)  was  tested  in  the 
absence of other drugs. 
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are extremely high and there was no previous indication that their diffusion rates in 
membranes were in any way restricted (Rhodes et al.,  1985).  Except for $207-180, 
we find that all DHPs have significantly lower c/s than trans affinities. The latter is a 
permanently charged analogue of PN200-110  in which the quaternary ammonium 
is  separated  from the  DHP ring by  10  methylene groups.  Apparently this  spacer 
chain is sufficiently long to ensure that the DHP moiety has no net charge, which 
would have otherwise reduced the pharmacological potency of the compound as in 
the case of a quaternary DHP tested by Uehara and Hume (1985).  Not only appar- 
ent affinities are different between the inside and the outside but the ranking order 
of DHPs  is  also  changed.  Potencies  on  the  c/s  sides  are  in  the  sequence  PN  > 
$207 >  NIF ~  (-)NIM  >  (+)NIM ~  NIM >  (+)BAY K >  NIT, while on the trans 
side the sequence is PN >  (-)NIM >  NIF ~  $207 ~  (+)NIM ~  +(BAY K >  NIM > 
NIT. In both sequences,  the affinity for PN200-110  is the highest.  The latter is in 
agreement with binding data  (Fig.  14)  and also in agreement with  single-channel 
data  in  cardiac  DHP  channels  (Hamilton  et  al.,  1987).  On  both  sides  also, 
(-)nimodipine  is  more  effective  than  (+)nimodipine  and  the  agonist  action  of 
(-)Bay  K  8644  has  higher  potency than  that  of the  antagonist  (+)Bay  K  8644. 
Again, these two results are in agreement with findings in heart Ca channels (Ham- 
ilton et al., 1987). Therefore, drugs added to either solution appear to gain access to 
a  bona fide DHP site although there are recognizable differences between c/s and 
trans effects and only trans  EDs0's correlate well with receptor binding EDs0's. 
We have considered the possibility that c/s and trans effects of DHPs reflect differ- 
ences in accessibility of DHPs to a single class of receptor sites in equilibrium with 
the external bulk solution.  In such a case, c/s-added DHPs would have to negotiate 
energetically its passage across the membrane to reach the binding site. The lower 
c/s affinity could  then be explained  by a  combination  of factors including  differ- 
ences in partition coefficients, ligand asymmetry, lateral diffusion,  interface distri- 
bution, and in general, by parameters that determine the diffusion rate of a solute 
across a membrane. We consider this alternative unlikely because, in our hands, the 
onset of DHPs was almost instantaneous in all cases and did not change significantly 
with time. That is, EDs0's did not depend to any great extent on the time of expo- 
sure  of channels  to  DHPs  as would  be  the  case  if access  rates were the  limiting 
factor. Moreover, chemically identical DHPs, such as pairs of enantiomers, appear 
to have different stereoselectivities on both sides. For example, (-)nimodipine has a 
25-fold difference between trans and c/s EDs0's while (+)nimodipine has a difference 
of only 12-fold. The ratio of affinities (+)nimodipine/(-)nimodipine  is 2.5 on the 
trans  side and 4.8 on the c/s side.  Because both steroisomers are expected to have 
identical  diffusional  properties it is unlikely the c/s and  trans  differences  reflect a 
difference in the rate of drug passage across the membrane. 
Rather than an accessibility difference, we favor the hypothesis that the sidedness 
of DHPs reflects the presence of a second DHP site associated with the Ca channel. 
Besides the results described for nimodipine above, there are significant differences 
in c/s and  trans  effects of (-)Bay  K  8644  which  suggest  two chemically different 
DHP binding sites. As shown in Fig. 5 the pure enantiomer agonist increased chan- 
nel lifetime on the trans  side but when present in the c/s side it decreased lifetime 
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decrease in apparent Hill coefficient or negative cooperativity seen in the presence 
of high  Ba (Fig.  14).  The existence  of high and low affinity DHP sites have been 
considered in numerous studies. Janis et al. (1984a) suggested this possibility on the 
basis of a  change in Hill coefficient for Bay K  8644  binding to heart membranes. 
The same conclusion was reached by others, based on a differential effect of diltia- 
zero on binding of DHP agonist and antagonists to cardiac membranes (Maan and 
Hosey, 1987, Rampe et al.,  1989).  Hamilton et al. (1987) and Williams et al. (1985) 
suggested two interacting sites in the Ca channel on the basis of the voltage depen- 
dence of DHPs, while Kokubun et al.  (1987)  noticed two sites in studies with pure 
enantiomer agonist-antagonist pairs of the DHP 202-791.  An independent  confir- 
mation of at least two binding sites in the DHP receptor of skeletal muscle has been 
provided by Scatchard  analysis of PN200-110  binding.  At  100  mM  Ba there  is a 
reduced binding capacity of [sH]PN200-100  to essentially a single class of binding 
sites (Fig.  14).  At low Ba (10  mM),  the Scatchard relationship is nonlinear with at 
least two binding components (Valdivia H., and R. Coronado, unpublished observa- 
tions).  Interestingly,  curvilinear Scatchard  plots for PN200-110  binding were not 
seen in Ca (Fosset et al.,  1983) which is the divalent of choice in most binding stud- 
ies but not in single-channel recording. Thus radioligand experiments as well as cel- 
lular recordings have recognized the need to postulate several DHP receptors asso- 
ciated to the Ca channel. 
The correlation of receptor binding and single-channel effects of DHPs suggested 
strongly  that  the  pure  component of the  Ca channel  and  the  170  kDa  0t 1 DHP 
receptor peptide are closely related and probably physically coupled.  This conclu- 
sion stems from our finding that when all sources of discrepancies between  DHP 
receptor  binding  and  Ca  channel  measurements  are  removed,  the  agreement 
between  DHP  effects on  radioligand  binding and  trans  channel  inhibition  is  out- 
standing.  Only  one  compound,  nitrendipine,  has  a  grossly low  affinity in  single- 
channel experiments and at the present we have no clues as to why this is the case. 
However, we realize that only one of three blocking mechanisms applicable to our 
protocols would predict a perfect 1:1  correlation between DHP blocking and bind- 
ing experiments. Since the channel did not open without agonist (Fig.  5), an open 
channel is a channel with agonist bound to it. Agonist-bound open channels may be 
blocked by an antagonist by one of three modes: (a) by displacement of the agonist 
and binding to the same site i.e.,  a competitive mode; (b) by binding to a  separate 
site that  functionally overrides  the  effect of the bound  agonist,  a  noncompetitive 
mode; and (c) by binding to a  separate site induced by bound agonist (such as to a 
state of the channel promoted by the agonist) i.e., an allosteric mode. Only a com- 
petitive  mode would  predict  a  perfect correlation,  whereas  in  noncompetitive or 
allosteric  modes,  the  correlation  would  depend  on  the  nature  of the  radioligand 
used and the degree of the coupling of agonist an antagonist  sites.  On the other 
hand, cis inhibition did not correlate well with high affinity DHP binding. We there- 
fore propose that the internal effects of DHPs are mediated by an entirely different 
class of low affinity receptors. Internally accessible DHP receptors may account for 
the suggestion ofJanis et al. (1988) that DHP-like molecules synthesized in the cell 
may serve as endogenous modulators of Ca channels. Mternatively, they may repre- 
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with DHPs (Callewaert et al.,  1989). These "internal" sites may serve also as recep- 
tors for phenylalkylamines (Hescheler et al.,  1982) and may not be present exclu- 
sively in the oq  DHP receptor peptide.  Home  et al. (1988) showed in a  solubilized 
and purified preparation of Ca channels of skeletal muscle that 45Ca flux activity 
assayed in liposomes, and sensitivity to micromolar levels of verapamil, resided in 
fractions with different peptide compositions. The flux activity required the a I pep- 
tide, whereas verapamil sensitivity resided in a  fraction that included 165  and 55 
kDa  proteins distinct from al  (Home  et  al.,  1988).  This latter  fraction was  also 
shown to block the inhibitory action of the G  protein Go. Thus part of its functional 
domain is likely to be intracellular as shown in the case of the excitatory effects of Gs 
on t tubule Ca channels (Yatani et al.,  1988). 
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